Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1577, 2007-01, pp. : 11-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Efalizumab may be a viable option for the treatment of psoriasis
Inpharma, Vol. 1, Iss. 1419, 2004-01 ,pp. :
Access to resources
Recommend
Ustekinumab: A New Option in Psoriasis Therapy
By Chien Anna L. Elder James T. Ellis Charles N.
Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. :
Tacrolimus a cost-saving option in renal transplantation in Europe
Inpharma, Vol. 1, Iss. 1412, 2003-01 ,pp. :
Tacrolimus a cost-saving option in renal transplantation in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 437, 2003-01 ,pp. :
Is tocilizumab an option for the treatment of arthritis?
Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. :